1. Introduction {#s0005}
===============

Cocaine is one of the most common drugs found in patients who seek EHC. In 2006, six million Americans aged 12 and older had abused cocaine in some form [@bb0005]. Cocaine is a potent vasoconstrictor ([@bb0010], [@bb0015], [@bb0020], Blaho, Merigian et al. 1996, Chang, Walsh et al. 2011). Some of its effects include hypertension, coronary vasospasm, accelerated atherosclerosis and myocardial infarction ([@bb0025], Chang, Walsh et al. 2011).

The most common symptom of cocaine abuse is chest pain [@bb0030]. CICP shares many of the common patho-physiologic pathways with acute coronary syndromes ([@bb0010], [@bb0035], Freeman and Feldman 2008). The use of BB, a cornerstone of the treatment of acute coronary syndromes has been thought to be contraindicated in patients using cocaine [@bb0040]. This is mainly because of theoretical UAE that can lead to hypertensive complications in patients intoxicated with the drug [@bb0030]. There are some reports of death associated with the use of beta blockers in patients using cocaine [@bb0045]. Coronary vasoconstriction was induced in one study when volunteers inhaled cocaine while intra-coronary propranolol was being infused [@bb0050]. Also, there have been reports of increased levels of cardiac biomarkers in patients who were given beta blockers while having cocaine induced chest pain [@bb0055].

Recent studies have been published showing that BB can be safely used in patients admitted for cocaine induced chest pain. ([@bb0025], [@bb0060], [@bb0065], Ibrahim, Maselli et al. 2013).

Continuing chest pain in patients who test positive for cocaine may be a marker for the continuing presence of the drug\'s systemic effects. We tried to observe the effects of the administration of BB early on admission which theoretically should have resulted in unopposed alpha stimulation. As a secondary endpoint we followed troponin levels during the admission and the patient\'s length of stay.

2. Methods {#s0010}
==========

We performed a retrospective review of all the medical records of patients admitted to a medical unit for cocaine induced chest pain to rule out acute coronary syndrome from June 2006 to June of 2009. All patients had a final diagnosis of cocaine induced chest pain and a positive urine test for cocaine metabolites.

Of the patients who received a beta blocker while having chest pain, the baseline blood pressure (BP) and heart rate (HR) were reviewed. Values were obtained 1 to 3 h after administration of the beta blocker and 3 to 6 h later. We also recorded the troponin I values on admission, 6 h after admission and 12 h later. We compared the results to a control group of patients (paired by age, sex, history of hypertension and race) also diagnosed with cocaine induced chest pain who did not receive beta blockers. Statistical comparison of the BP and the HR was done using the Mann--Whitney test. The troponin values were compared using the Fisher\'s exact test. The use of beta blockers was at the discretion of the Emergency Department Physicians.

The data was evaluated using Graph-pad software.

3. Results {#s0015}
==========

We found a total 378 patients who were diagnosed with CICP and admitted to rule out an acute coronary syndrome. From this group we identified 26 that while having chest pain received a dose of BB in the Emergency Department. The type and route of the BB were: oral metoprolol 13 patients (50%), intravenous metoprolol 5 patients (19%), intravenous labetalol 2 patients (8%), oral carvedilol 2 patients (8%), oral atenolol 2 patients (8%), and oral propranolol 2 patients (8%).

No statistically significant differences were noted in the demographics of the patients who received and who did not receive beta blockers. This is outlined in [Table 1](#t0005){ref-type="table"}.Table 1Comparison of the basic compared characteristic of the patients groups.Patient characteristicsB-blockers usedB-blockers not usedP value(n = 26)(n = 32)Age (in years)5048.30.4216Sex (male)23 (88.5%)30 (93.8%)0.8078Race0.6181    Black14 (53.8%)15 (46.9%)    Hispanic10 (38.5%)16 (50.0%)    White2 (7.7%)1 (3.1%)History of hypertension18 (69.2%)18 (56.3%)0.4163

The group with higher BP and HR was more likely to receive BB. However, there was no statistically significant difference between the two groups. At 6 and 12 h after admission the heart rate and the blood pressure were lower in the BB group. The results are in [Table 2](#t0010){ref-type="table"}.Table 2Comparison of the blood pressure and heart rate in patients with CICP who received and did not received beta blockers early on admission.TimeBlood pressure and heart rate in patients that received beta blockersBlood pressure in patients that did not receive beta blockersP valueAverage (95% CI)Average (95% CI)0 to 1 hSystolic147.8 (136.5 to 159.1)Systolic135.5 (127.9 to 143.1)0.0647Diastolic88.5 (80.9 to 96.0)Diastolic82.5 (77.7 to 87.3)0.1730Mean108.2 (99.9 to 116.4)Mean100.17 (94.8 to 105.6)0.0966Heart rate86.4 (80.7 to 92.1)Heart rate87.6 (81.8 to 93.4)0.77861--3 hSystolic135.1 (126.1 to 143.9)Systolic133.3 (124.2 to 142.4)0.8053Diastolic80.01 (72.9 to 87.3)Diastolic77.5 (72.4 to 82.8)0.5951Mean98.42 (91.0 to 105.8)Mean96.1 (89.9 to 102.3)0.6662Heart rate79.63 (75.3 to 83.9)Heart rate79.1 (74.3 to 83.9)0.89113 to 6 hSystolic126.7 (118.3 to 135.2)Systolic130.1 (123.9 to 136.4)0.5177Diastolic75.57 (69.7 to 81.5)Diastolic76.9 (72.3 to 81.6)0.7150Mean92.62 (86.4 to 98.9)Mean94.7 (90.2 to 99.1)0.5893Heart rate73.11 (68.7 to 77.6)Heart rate75.8 (71.1 to 80.5)0.4222

There was no statistically significant difference in the troponin levels between the two groups studied ([Table 3](#t0015){ref-type="table"}).Table 3Comparison of the troponin trend in between patients with CICP who received and did not received beta blockers early on admission.TimeNumber of patients with Troponins (+) among those that received B-blockers (mean value)Number of patients with Troponins (+) among those that did not receive B-blockers (mean value)P value0--3 h7/26 (0.1631)7/32 (0.5406)0.89003--6 h4/26 (0.0923)5/32 (0.0372)0.76126--12 h3/26 (0.0130)5/32 (0.0597)1.000

The length of stay was significantly different (4.6 days in the case group and 2.65 days in the control group, P: 0.04). However, this might be affected by the presence of patients who stayed in the hospital because of unrelated issues in both groups.

No cardiac complications were found, and no in-hospital mortality occurred in either group.

4. Discussion {#s0020}
=============

In our study, the use of BB did not appear to harm patients with continuing CICP.

We did not observe any documented adverse effects in the cocaine positive group that received a beta blocker when compared to a similar group of patients who did not receive the beta blocker. There were no statistically significant differences between systolic, diastolic and mean arterial BP as well as HR. However, the BP and HR in the beta blocker group at 6 and 12 h were lower than the ones in the control group. This finding is not consistent with the presence of an "unopposed alpha effect" in patients using cocaine treated with beta blockers.

There were no differences between the troponin trend in both groups at any time. The length of stay was increased in the group of patients that received the BB. This might be secondary to unrelated co-morbidities and social problems that prevented discharge.

In 2013 in the United States, 24.6 million Americans aged 12 and older were current illicit drug users. There were 1.5 million cocaine users aged 12 or older. [@bb0070]. Cocaine is the most common drug associated to visits to the Emergency Department [@bb0075]. The most common reason for obtaining a consult in the Emergency Department in cocaine users is chest pain [@bb0030].

Cocaine is a potent sympathomimetic. It becomes bioavailable when absorbed through a mucosal membrane, when inhaled, ingested, injected or smoked (as in its "crack" form). It acts by blocking the re-uptake of norepinephrine in the presynaptic membrane. This is associated with a significant increase of the nor-adrenergic tone leading to vasoconstriction, hypertension, increased myocardial contractility and tachycardia. Cocaine is also associated with early atherosclerosis and thrombus formation including thrombotic myocardial infarctions [@bb0080]. Despite the proven benefit of BB in ischemic heart disease this therapy is contraindicated in patients with chest pain secondary to cocaine [@bb0040]. There have been other studies that have found no harm of the use of BB in patients with cocaine induced chest pain ([@bb0085], [@bb0090], [@bb0095], Self, Rogers et al. 2011, Fanari, Kennedy et al. 2014). In one study the use of beta blockers was associated with decreased long term mortality in patients with cocaine induced chest pain [@bb0060].

This study was designed to find evidence of the presence of an unopposed nor-adrenergic state in patients who had evidence of continuing cocaine induced chest pain when treated with beta blockers.

It is important to note that all the patients included in our study had continuing chest pain at the moment the BBs were administered in the Emergency Department. Because of this we can theorize that these patients were at increased risk of suffering from acute cocaine toxicity and therefore at increased risk of having adverse effects from the beta blocker [@bb0100], this was not observed in our study. Interestingly the patients in our study who received beta blockers were more hypertensive and tachycardic on admission than the control group however in the group that received a BB both heart rate and blood pressure were lower at 6 and 12 h blockers compared to the group that did not receive a beta blocker.

Our study has several limitations. Because this is a retrospective review of medical records, the patients did not have a standardized protocol for follow-up after therapy with beta blockers was started. Different beta blockers were used, and administration was both intravenous and oral. Also it is important to state that the beta blockers were given to patients with acute cocaine induced chest pain and were discontinued after determining the presence of cocaine metabolites in the urine. The test for the presence of cocaine metabolites in the urine is a qualitative analysis and we cannot estimate the amount of cocaine ingested by the patients in either group.

Our study does not support the theory of an UAE in patients who received BB while having CICP in the Emergency Department. Our conclusions are supported by not finding a statistical difference in troponin levels or cocaine associated complications either group.

This study was performed at the Metropolitan Hospital Center, New York, NY. IRB was approved by the New York Medical College and Hospital Health Corporation. No funding was received.
